Jeff E. Knight

Chief Dev. & Operating Officer

Chief Dev. & Operating Officer at Crinetics Pharmaceuticals, Inc., filing insider transactions between 2026-03-16 and 2026-04-08.

Total Purchases

—

0 transactions

Total Sales

$3.8M

3 transactions

Companies Traded

3 total filings

Active Since

2026-03-16

Last: 2026-04-08

Companies

Crinetics Pharmaceuticals, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-04-08	CRNX	Sale	85.2K	$40.10	$3.4M	105.3K	SEC ↗
2026-03-16	CRNX	Sale	5,950	$37.11	$221K	116.0K	SEC ↗
2026-03-16	CRNX	Sale	3,961	$37.77	$150K	112.0K